Education

• 2004.08

  Doctor of Medicine : Yonsei University

• 1999.02

  Master of Medicine : Yonsei University

• 1996.02

  Bachelor of Medicine : Yonsei University

Career

• 2015.03 ~ present

  Professor in Pathology, Inha University Hospital

• 2012.02 ~ 2013.02

  Training in MD Anderson Cancer Center

• 2010.01 ~ 2015.02

  Associate Professor in Pathology, Inha University Hospital

• 2006.01 ~ 2010.02

  Assistant Professor in Pathology, Inha University Hospital

• 2002.01 ~ 2006.01

  Fellow, Inha University Hospital

• 2001.01 ~ 2002.01

  Fellow, Yonsei University College of Medicine

• 1997.03 ~ 2001.02

  Resident, Severance Hospital

• 1996.03 ~ 1997.02

  Intern, Severance Hospital

Professional Activities

• -

  a member of the Korean Society for Pathology.

• -

  a regular member of the Korean Society for Cell Pathology.

• -

  a regular member of the Korean Lung Cancer Society.

• -

  The regular member of International Association for the Study of Lung Cancer (IASLC)

Honors

Research & Publications

• 2017

  Prognostic implication of semi-quantitative immunohistochemical assessment of CD20 expression in diffuse large B cell lymphoma

• 2017

  High-quality cell block preparation from scraping of conventional cytology slide: a technical report on a modified cytoscrape cell block technique

• 2017

  Tumor tissue sampling for lung cancer management in the era of personalized therapy: What is good enough for molecular testing?

• 2016

  The effect of neutral surface iron oxide nanoparticles on cellular uptake and signaling pathways

• 2016

  Ciliated muconodular papillary tumor of the lung harboring BRAF V600E mutation and p16 INK4a overexpression without proliferative activity may represent an example of oncogene-induced senescence

• 2016

  Molecular testing of lung cancers

• 2014

  Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients